Myeloid Malignancy Interest Group

f8391a7e01813b5978cbafaa9bd5c08e

The Myeloid Malignancy Interest Group is an NIH-wide multidisciplinary network of researchers and clinicians dedicated to improving early detection, diagnosis, prognosis and development of novel therapeutics for myeloid malignancies. For more information, see https://ccr.cancer.gov/myeloid-malignancies-program .

Representatives of this interest group include:

• Peter D. Aplan, M.D.
• Paul Liu, Ph.D.
• Steven Z. Pavletic, M.D.
• Nirali N. Shah, M.D.

aplanp@mail.nih.gov NCI-CCR Peter Aplan, M.D https://irp.nih.gov/pi/peter-aplan pliu@nhgri.nih.gov NHGRI https://irp.nih.gov/pi/paul-liu Scientific Interest Groups nirali.shah@nih.gov Nirali Shah, M.D. https://ccr.cancer.gov/Pediatric-Oncology-Branch/nirali-n-shah hourigancs@mail.nih.gov Virginia Tech Christopher Hourigan, M.D., D.Phil. https://fbri.vtc.vt.edu/people-directory/primary-faculty/hourigan.html pavletis@mail.nih.gov Steven Pavletic, M.D. https://irp.nih.gov/pi/steven-pavletic https://list.nih.gov/cgi-bin/wa.exe?SUBED1=MYELOID-SIG&A=1